Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

Acute effects of walking in forest environments on cardiovascular and metabolic parameters.

Li Q, Otsuka T, Kobayashi M, Wakayama Y, Inagaki H, Katsumata M, Hirata Y, Li Y, Hirata K, Shimizu T, Suzuki H, Kawada T, Kagawa T.

Eur J Appl Physiol. 2011 Nov;111(11):2845-53. doi: 10.1007/s00421-011-1918-z. Epub 2011 Mar 23.

PMID:
21431424
2.

A day trip to a forest park increases human natural killer activity and the expression of anti-cancer proteins in male subjects.

Li Q, Kobayashi M, Inagaki H, Hirata Y, Li YJ, Hirata K, Shimizu T, Suzuki H, Katsumata M, Wakayama Y, Kawada T, Ohira T, Matsui N, Kagawa T.

J Biol Regul Homeost Agents. 2010 Apr-Jun;24(2):157-65.

PMID:
20487629
3.

Effects of Forest Bathing on Cardiovascular and Metabolic Parameters in Middle-Aged Males.

Li Q, Kobayashi M, Kumeda S, Ochiai T, Miura T, Kagawa T, Imai M, Wang Z, Otsuka T, Kawada T.

Evid Based Complement Alternat Med. 2016;2016:2587381. doi: 10.1155/2016/2587381. Epub 2016 Jul 14.

4.

Visiting a forest, but not a city, increases human natural killer activity and expression of anti-cancer proteins.

Li Q, Morimoto K, Kobayashi M, Inagaki H, Katsumata M, Hirata Y, Hirata K, Suzuki H, Li YJ, Wakayama Y, Kawada T, Park BJ, Ohira T, Matsui N, Kagawa T, Miyazaki Y, Krensky AM.

Int J Immunopathol Pharmacol. 2008 Jan-Mar;21(1):117-27.

PMID:
18336737
5.

A forest bathing trip increases human natural killer activity and expression of anti-cancer proteins in female subjects.

Li Q, Morimoto K, Kobayashi M, Inagaki H, Katsumata M, Hirata Y, Hirata K, Shimizu T, Li YJ, Wakayama Y, Kawada T, Ohira T, Takayama N, Kagawa T, Miyazaki Y.

J Biol Regul Homeost Agents. 2008 Jan-Mar;22(1):45-55.

PMID:
18394317
6.

N-terminal B-type natriuretic peptide concentrations are similarly increased by 30 minutes of moderate and brisk walking in patients with coronary artery disease.

Scharhag J, Herrmann M, Weissinger M, Herrmann W, Kindermann W.

Clin Res Cardiol. 2007 Apr;96(4):218-26. Epub 2007 Feb 26.

PMID:
17323015
7.

Forest bathing enhances human natural killer activity and expression of anti-cancer proteins.

Li Q, Morimoto K, Nakadai A, Inagaki H, Katsumata M, Shimizu T, Hirata Y, Hirata K, Suzuki H, Miyazaki Y, Kagawa T, Koyama Y, Ohira T, Takayama N, Krensky AM, Kawada T.

Int J Immunopathol Pharmacol. 2007 Apr-Jun;20(2 Suppl 2):3-8.

PMID:
17903349
8.

Association between N-terminal pro-brain natriuretic peptide and adiponectin in healthy Japanese men.

Nakanishi K, Nishida M, Yamamoto R, Koseki M, Moriyama T, Yamauchi-Takihara K.

Clin Chim Acta. 2016 Sep 1;460:138-41. doi: 10.1016/j.cca.2016.06.029. Epub 2016 Jun 25.

PMID:
27350292
9.

N-terminal pro brain natriuretic peptide is inversely related to metabolic cardiovascular risk factors and the metabolic syndrome.

Olsen MH, Hansen TW, Christensen MK, Gustafsson F, Rasmussen S, Wachtell K, Borch-Johnsen K, Ibsen H, Jørgensen T, Hildebrandt P.

Hypertension. 2005 Oct;46(4):660-6. Epub 2005 Aug 29.

10.

Perindopril-based blood pressure-lowering therapy reduces amino-terminal-pro-B-type natriuretic peptide in individuals with cerebrovascular disease.

Campbell DJ, Woodward M, Chalmers JP, Colman SA, Jenkins AJ, Kemp BE, Neal BC, Patel A, MacMahon SW.

J Hypertens. 2007 Mar;25(3):699-705.

PMID:
17278987
11.

The value of N-terminal pro-B-type natriuretic peptide in determining antihypertensive benefit: observations from the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT).

Welsh P, Poulter NR, Chang CL, Sever PS, Sattar N; ASCOT Investigators.

Hypertension. 2014 Mar;63(3):507-13. doi: 10.1161/HYPERTENSIONAHA.113.02204. Epub 2013 Dec 9.

12.

Echocardiographic assessment and N-terminal pro-brain natriuretic peptide in hypertensives with metabolic syndrome.

Krzesiński P, Uziebło-Życzkowska B, Gielerak G, Stańczyk A, Piotrowicz K, Piechota W, Smurzyński P, Skrobowski A.

Adv Clin Exp Med. 2017 Mar-Apr;26(2):295-301. doi: 10.17219/acem/33554.

13.
15.

Hyperthyroidism may affect serum N-terminal pro-B-type natriuretic peptide levels independently of cardiac dysfunction.

Arikan S, Tuzcu A, Gokalp D, Bahceci M, Danis R.

Clin Endocrinol (Oxf). 2007 Aug;67(2):202-7. Epub 2007 Jun 4.

PMID:
17547691
16.
17.

[Factors associated plasma B type natriuretic peptide and N-terminal pro-B-type natriuretic peptide levels].

Chen Y, Yao CL, Shimada T.

Zhonghua Xin Xue Guan Bing Za Zhi. 2008 Sep;36(9):825-30. Chinese.

PMID:
19102867
18.

N-terminal pro-brain natriuretic peptide, C-reactive protein, and urinary albumin levels as predictors of mortality and cardiovascular events in older adults.

Kistorp C, Raymond I, Pedersen F, Gustafsson F, Faber J, Hildebrandt P.

JAMA. 2005 Apr 6;293(13):1609-16.

PMID:
15811980
19.

Serum N-terminal-pro-B-type natriuretic peptide (NT-pro-BNP) levels in hyperthyroidism and hypothyroidism.

Ozmen B, Ozmen D, Parildar Z, Mutaf I, Bayindir O.

Endocr Res. 2007;32(1-2):1-8.

PMID:
18271501
20.

Association between N-terminal pro B-type natriuretic peptide and day-to-day blood pressure and heart rate variability in a general population: the Ohasama study.

Satoh M, Hosaka M, Asayama K, Kikuya M, Inoue R, Metoki H, Tsubota-Utsugi M, Hara A, Hirose T, Obara T, Totsune K, Hoshi H, Mano N, Node K, Imai Y, Ohkubo T.

J Hypertens. 2015 Aug;33(8):1536-41. doi: 10.1097/HJH.0000000000000570.

PMID:
25827428

Supplemental Content

Support Center